Multiple regions of ETO cooperate in transcriptional repression.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 11150306)

Published in J Biol Chem on January 09, 2001

Authors

D Hildebrand1, J Tiefenbach, T Heinzel, M Grez, A B Maurer

Author Affiliations

1: Georg-Speyer-Haus, Institute for Biomedical Research, Paul-Ehrlich Strasse 42-44, 60596 Frankfurt, Germany.

Articles citing this

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J (2003) 2.81

ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60

Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Mol Cell Biol (2008) 1.29

Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Mol Cell Biol (2005) 1.16

PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood (2012) 1.07

RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood (2008) 1.02

Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery. Mol Cell Biol (2009) 0.92

High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24). Leukemia (2012) 0.92

Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol (2005) 0.90

Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation. Cancer Lett (2006) 0.89

A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy. Blood (2006) 0.87

Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. EMBO J (2012) 0.83

Novel RNA-binding properties of the MTG chromatin regulatory proteins. BMC Mol Biol (2008) 0.81

Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs. Front Oncol (2014) 0.81

The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues. BMC Mol Biol (2008) 0.80

The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells. BMC Mol Biol (2010) 0.80

RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1. Oncogenesis (2015) 0.78

The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells. BMC Mol Biol (2012) 0.78

The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration. PLoS One (2013) 0.78

Interference with RUNX1/ETO leukemogenic function by cell-penetrating peptides targeting the NHR2 oligomerization domain. Biomed Res Int (2013) 0.76

Role of RUNX1 in hematological malignancies. Blood (2017) 0.75

Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. PLoS One (2015) 0.75

New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins. Front Biol (Beijing) (2016) 0.75

Articles by these authors

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science (1993) 8.49

5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Res (1981) 8.10

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J (2001) 6.85

Exons encode functional and structural units of chicken lysozyme. Proc Natl Acad Sci U S A (1980) 4.01

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55

Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46

Signal-specific co-activator domain requirements for Pit-1 activation. Nature (1998) 2.22

Histone deacetylase as a therapeutic target. Trends Endocrinol Metab (2001) 1.83

P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A (1995) 1.77

HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS (1993) 1.68

Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.68

Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60

A role of Ia-associated invariant chains in antigen processing and presentation. Cell (1989) 1.55

VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J (2000) 1.52

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial. Br J Cancer (2007) 1.52

Synthesis of ds-cDNA involving addition of dCMP tails to allow cloning of 5'-terminal m RNA sequences. Methods Enzymol (1983) 1.46

Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene (2010) 1.38

Expression of a chicken lysozyme recombinant gene is regulated by progesterone and dexamethasone after microinjection into oviduct cells. Cell (1982) 1.37

Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des (2004) 1.31

Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature (1983) 1.25

Determinants of retrovirus gene expression in embryonal carcinoma cells. J Virol (1991) 1.21

Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther (2008) 1.11

Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques (2001) 1.09

Progress and prospects: gene therapy clinical trials (part 1). Gene Ther (2007) 1.09

Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes. Mol Endocrinol (1997) 1.08

Structure of the lysozyme gene and expression in the oviduct and macrophages. Haematol Blood Transfus (1981) 1.06

Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter. Gene Ther (2011) 1.06

Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis. Oncogene (2007) 1.04

Self-deleting retrovirus vectors for gene therapy. J Virol (1996) 1.01

Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J (1996) 1.00

Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation. Leukemia (2010) 0.99

Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents. J Biol Chem (1997) 0.97

The Bof protein of bacteriophage P1 exerts its modulating function by formation of a ternary complex with operator DNA and C1 repressor. J Biol Chem (1992) 0.95

A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther (2009) 0.93

T cells for suicide gene therapy: activation, functionality and clinical relevance. J Immunol Methods (2007) 0.93

Histone arginine methylation keeps RUNX1 target genes in an intermediate state. Oncogene (2012) 0.93

High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood (1996) 0.92

Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther (2002) 0.91

Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther (2003) 0.91

Transient expression of the chicken lysozyme gene after transfer into human cells. EMBO J (1982) 0.90

SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation. Oncogene (2012) 0.89

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation. Gene Ther (2009) 0.89

Energy spectra of quantum rings. Nature (2001) 0.89

The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J Biol Chem (1998) 0.88

Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro. Gene Ther (2000) 0.86

Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther (1998) 0.85

Quantized magnetic confinement in quantum wires. Phys Rev Lett (2010) 0.84

Selection of HIV-1 genotypes by cultivation in different primary cells. AIDS (1999) 0.84

A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector. Hum Gene Ther (2000) 0.84

The isolation and characterization of the chicken lysozyme and ovomucoid gene. J Steroid Biochem (1980) 0.83

Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation. Stem Cells (1996) 0.83

Histamine release from basophils after in vivo application of recombinant human interleukin-3 in man. Int Arch Allergy Appl Immunol (1990) 0.83

High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood (1998) 0.82

Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res (2002) 0.81

Kaposi's sarcoma in an Indian woman infected with HIV-1 and HIV-2. AIDS Res Hum Retroviruses (1993) 0.79

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. Oncogene (2012) 0.79

MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol Ther (2000) 0.79

Distribution and infection of Langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients. Res Virol (1993) 0.78

DNA-dependent cofactor selectivity of the glucocorticoid receptor. Ernst Schering Res Found Workshop (2002) 0.76

[The significance and evaluation of Frank's orthogonal electrocardiogram]. Vnitr Lek (1979) 0.75

[Molecular mechanisms of hematopoietic stem cell differentiation]. Internist (Berl) (1995) 0.75

Influence of the polymerization potential on the transport properties of polypyrrole films. J Phys Chem B (2010) 0.75

Shot noise by quantum scattering in chaotic cavities. Phys Rev Lett (2001) 0.75

[Rheography of the limbs]. Vnitr Lek (1978) 0.75

High protective action against gamma radiation damage, by a tryptophan-ethanol mixture. Z Naturforsch B (1972) 0.75

[Kartagener's syndrome--the ciliary dyskinesia syndrome]. Vnitr Lek (1984) 0.75

[Nephrocalcinosis]. Vnitr Lek (1975) 0.75

[Determination of zinc in body fluids, evaluation of the results and its significance in internal medicine]. Vnitr Lek (1987) 0.75

[Calcification in diffuse scleroderma]. Fysiatr Revmatol Vestn (1981) 0.75

[Incidence and significance of cryoglobulinemias in clinical practice]. Vnitr Lek (1976) 0.75

Signatures of spin pairing in chaotic quantum dots. Phys Rev Lett (2001) 0.75

[Zinc--an essential trace element, its distribution in the human body, its biologic function and metabolism]. Vnitr Lek (1986) 0.75

[Aortic aneurysm with aortic valve insufficiency in Marfan's syndrome]. Vnitr Lek (1978) 0.75

[Familial renal tubular acidosis]. Vnitr Lek (1981) 0.75

Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras. Gene Ther (1998) 0.75

[Effect of lactation on the weight and body composition of wet nurses]. Arch Latinoam Nutr (1983) 0.75

Expression of the chicken lysozyme gene after transfer into homologous and heterologous cells. Prog Clin Biol Res (1982) 0.75

Affinity chromatography of poly(A) polymerase on ATP-Sepharose. FEBS Lett (1977) 0.75

[Occurrence of lead in food and in the human body; its biological function and metabolism]. Vnitr Lek (1988) 0.75